The Crohn's & Colitis Foundation of America and RMEI Medical Education Launch National IBD Co-Learning Initiative for Clinicians and Patients

The Clinical Convergence(SM) conference series and web course will bring gastroenterology clinicians and patients with IBD together in a first-of-its-kind educational event

May 18, 2016, 10:00 ET from RMEI Medical Education

NEW YORK, May 18, 2016 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) and RMEI Medical Education (RMEI) will launch a national continuing medical education (CME) curriculum to engage both patients and clinicians on better collaborative management of and communication around inflammatory bowel diseases (IBD). Titled Clinical ConvergenceSM: Patient and Provider Perspectives in IBD, the first iteration of the initiative will launch in September 2016 with two half-day conferences for patients and providers, and an interactive online course. More information, including registration, will be available on this summer.

"As the leading advocate for patients with IBD and the clinicians who care for them, CCFA is excited to share this innovative approach to education with our member community," said Laura Wingate, Vice President of Patient & Professional Services at CCFA. "By bringing patients into the educational discourse with clinicians, our goal is to stimulate a more informed and collaborative approach to IBD management."

Supported by independent educational grant funding from AbbVie, Takeda Pharmaceuticals USA, and UCB, the first meetings will kick off on September 10 in Memphis, TN, and September 24 in Phoenix, AZ. Physicians, nurse practitioners, and physician assistants will engage in interactive CME courses throughout the morning while patients participate in a parallel track specific to their needs. Just before lunch, both groups will "converge" into a single session for a structured discussion on best practices for care and how well they translate into the actual patient experience.   

"With the evolving definition of value in the healthcare delivery system, clinicians are being increasingly measured and reimbursed by health systems based on patient satisfaction scores and engagement metrics," said Dr. Jacqui Brooks, Senior Vice President of Medical Strategy at RMEI. "The Clinical ConvergenceSM series was built to empower the patient and, especially, the healthcare provider to be more effective in the disease management and communication process."

Known collectively as IBD, Crohn's disease and ulcerative colitis affects 1 in 200 people. They are painful, medically incurable diseases that attack the digestive system. Crohn's disease may attack anywhere along the digestive tract, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require numerous hospitalizations and surgery. Most people develop the diseases between the ages of 15 and 35; however the incidence is increasing in children.

About the Crohn's & Colitis Foundation of America
The Crohn's & Colitis Foundation of America (CCFA) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). CCFA's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research; providing educational resources for patients and their families, medical professionals, and the public; and furnishing supportive services for those afflicted with IBD. For more information visit, call 888-694-8872, or email

About RMEI Medical Education
Founded in 1990, RMEI Medical Education (RMEI) is one of the longest operating medical education companies in the U.S. With an emphasis on sophisticated learner analytics for program design, delivery and assessment, RMEI works to elevate the dialogue on what makes for effective education. In designing innovative teaching modalities such as the Clinical Convergence™ platform for its five primary therapeutic areas, RMEI seeks to inspire greater collaboration within the care team and stronger commitment to patient engagement. For more information, visit, call 856-672-3152 or email at

Photo -
Photo -


SOURCE RMEI Medical Education